Synergistic effect of hyaluronate fragments in retinaldehyde-induced skin hyperplasia which is a Cd44-dependent phenomenon

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Barnes, Laurent ^a   Tran, Christian ^a   Sorg, Olivier ^a   Hotz, Raymonde ^a   Grand, Denise ^a   Carraux, Pierre ^a   Didierjean, Liliane ^a   Stamenkovic, Ivan ^b   Saurat, Jean Hilaire ^a   Kaya, Gürkan ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HERMES ANTIGEN; HYALURONIC ACID; HYMECROMONE; MATRILYSIN; RETINAL; RETINOIC ACID; RETINOID; RETINOL; RETINOL PALMITATE; STROMELYSIN; EGFR PROTEIN, HUMAN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOPOROSIS; DRUG POTENCY; EPIDERMIS HYPERPLASIA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SKIN ATROPHY; SKIN DISEASE; TREATMENT DURATION; WILD ANIMAL; ANIMAL; ATROPHY; CHEMISTRY; CYTOLOGY; DBA MOUSE; EPIDERMIS; FEMALE; GENETICS; HYPERPLASIA; MALE; METABOLISM; MIDDLE AGED; TRANSGENIC MOUSE;

MUS;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD44; ATROPHY; EPIDERMIS; FEMALE; HUMANS; HYALURONIC ACID; HYPERPLASIA; KERATINOCYTES; MALE; MICE; MICE, INBRED DBA; MICE, TRANSGENIC; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINALDEHYDE; SKIN DISEASES;

EID: 78650738010     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014372     Document Type: Article

References (22)

1. Stamenkovic I, Aruffo A, Amiot M, Seed B (1991) The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10: 343-348.
2. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, et al. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci 89: 12160-12164.
3. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313.
4. Miyake K, Underhill CB, Lesley J, Kincade PW (1990) Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172: 69-75.
5. Laurent TC, Fraser JR (1992) Hyaluronan. FASEB J 6: 2397-2404.
6. Kaya G, Rodriguez I, Jorcano JL, Vassalli P, Stamenkovic I (1997) Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev 11: 996-1007.
7. Kaya G, Grand D, Hotz R, Augsburger E, Carraux P, et al. (2005) Upregulation of CD44 and hyaluronate synthases by topical retinoids in mouse skin. J Invest Dermatol 124: 284-287.
8. Calikoglu E, Sorg O, Tran C, Grand D, Carraux P, et al. (2006) UVA and UVB decrease the expression of CD44 and hyaluronate in mouse epidermis which is counteracted by topical retinoids. Photochem Photobiol 82: 1342-1347.
9. Kaya G, Saurat JH (2005) Restored epidermal CD44 expression in lichen sclerosus et atrophicus and clinical improvement with topical application of retinaldehyde. Br J Dermatol 152: 570-572.
10. Kaya G, Augsburger E, Stamenkovic I, Saurat JH (2000) Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus. J Invest Dermatol 115: 1054-1058.
11. Saurat JH, Didierjean L, Masgrau E, Piletta PA, Jaconi S, et al. (1994) Topical retinaldehyde on human skin: biologic effects and tolerance. J Invest Dermatol 103: 770-774.
12. Didierjean L, Carraux P, Grand D, Sass JO, Nau H, et al. (1996) Topical retinaldehyde increases skin content of retinoic acid and exerts biologic activity in mouse skin. J Invest Dermatol 107: 714-719.
13. Xiao JH, Feng X, Di W, Peng ZH, Li LA, et al. (1999) Identification of heparinbinding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors. EMBO J 18: 1539-1548.
14. Yu WH, Woessner JF, Jr., McNeish JD, Stamenkovic I (2002) CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16: 307-323.
15. Kaya G, Tran C, Sorg O, Hotz R, Grand D, et al. (2006) Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanism. PLoS Med 3(12): e493.
16. Kaya G, Saurat JH (2007) Dermatoporosis: a chronic cutaneous insufficiency/ fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments. Dermatology 215: 284-294.
17. Kaya G, Jacobs F, Prins C, Viero D, Kaya A, et al. (2008) Deep dissecting hematoma: An emerging severe complication of dermatoporosis. Arch Dermatol 144: 1303-1308.
18. Hudson DL, Sleeman J, Watt FM (1995) CD44 is the major peanut lectinbinding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J Cell Sci 108: 1959-1970.
19. Xian W, Rosenberg MP, DiGiovanni J (1997) Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion. Oncogene 14: 1435-1444.
20. Piepkorn M, Predd H, Underwood R, Cook P (2003) Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factorrelated factors and erbB receptors by normal and psoriatic human keratinocytes. Arch Dermatol Res 295: 93-101.
21. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, et al. (1995) CD44 isoforms containing exon V3 are responsible for the presentation of heparinbinding growth factor. J Cell Biol 128: 687-698.
22. Higashiyama S, Nanba D (2005) ADAM-mediated ectodomain shedding of HBEGF in receptor cross-talk. Biochim Biophys Acta 1751: 110-117.